These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3055174)

  • 1. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T; Yamaguchi A; Hiruma R
    Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of permeability in the activities of beta-lactams against gram-negative bacteria which produce a group 3 beta-lactamase.
    Matsumura N; Minami S; Watanabe Y; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2084-6. PubMed ID: 10428944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H; Normark S
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An explicit model for bacterial resistance: application to beta-lactam antibiotics.
    Waley SG
    Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteria.
    Livermore DM
    Rev Infect Dis; 1988; 10(4):691-8. PubMed ID: 3142011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--I. Steady-state treatment.
    Frère JM
    Biochem Pharmacol; 1989 May; 38(9):1415-26. PubMed ID: 2785796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):310-6. PubMed ID: 6991466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.
    Lindberg F; Normark S
    Rev Infect Dis; 1986; 8 Suppl 3():S292-304. PubMed ID: 3529322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
    Acar JF; Minozzi C
    Rev Infect Dis; 1986; 8 Suppl 5():S482-6. PubMed ID: 3541133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of the mechanisms of resistance to beta-lactam antibiotics.
    Frère JM; Joris B; Granier B; Matagne A; Jacob F; Bourguignon-Bellefroid C
    Res Microbiol; 1991; 142(6):705-10. PubMed ID: 1961980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Porins and β-Lactamase in Outer Membrane Vesicles on the Hydrolysis of β-Lactam Antibiotics.
    Kim SW; Lee JS; Park SB; Lee AR; Jung JW; Chun JH; Lazarte JMS; Kim J; Seo JS; Kim JH; Song JW; Ha MW; Thompson KD; Lee CR; Jung M; Jung TS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants.
    Mett H; Rosta S; Schacher B; Frei R
    Rev Infect Dis; 1988; 10(4):765-9. PubMed ID: 3263685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the cell-surface-associated enzyme in the Zimmermann-Rosselet assay of outer membrane permeability of beta-lactam antibiotics.
    Liu W; Nikaido H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):177-9. PubMed ID: 2014974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria.
    Farmer TH; Degnan BA; Payne DJ
    FEMS Microbiol Lett; 1999 Jul; 176(1):11-5. PubMed ID: 10418127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa.
    Hancock RE; Woodruff WA
    Rev Infect Dis; 1988; 10(4):770-5. PubMed ID: 2460909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.